Verastem reported $21.4M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
AstraZeneca AZN:LN 840.42B 39.99B
Curis CRIS:US $ 17.45M 264K
Cytokinetics CYTK:US $ 99.84M 18.14M
Epizyme EPZM:US $ 57.33M 2.29M
Gilead Sciences GILD:US $ 4231M 2162M
Immunogen IMGN:US $ 75.22M 14.28M
Laboratory Of America LH:US $ 3171M 40.7M
Novartis NOVN:VX 10.86B 895M
Pfizer PFE:US $ 15640M 148M
Tg Therapeutics TGTX:US $ 39.53M 29.35M
Verastem VSTM:US $ 21.4M 1.83M
YTE INCY:US $ 656.97M 40.27M
Ziopharm Oncology ZIOP:US $ 9.23M 148K